Development and Primary Evaluation of a Smartphone Application for Blood Glucose Control in Hospitalized Patients

Document Type : Original Article


1 Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran


Background: Diabetes is one of the major causes of morbidity and mortality. Diabetes and hyperglycemia are leading causes for cardiovascular diseases, chronic infections, and other serious problems. The use of smartphone is dramatically increasing, and as such, it is sensible to use an application for management of hospitalized patients with diabetes or hyperglycemia. We designed a software for physicians by use of which they educate to take appropriate decisions in management of patients with diabetes and evaluated the quality of the application using a questionnaire. Materials and Methods: Application is designed in a cascade framework to help in management of patients with diabetes and hyperglycemia. The treatment protocols presented in the program were extracted from diabetes management guidelines and valid review articles. Furthermore, we developed a questionnaire to assess the quality of the program. Physicians (n = 36) used this program for 1 week after which they completed the questionnaire. Results: The physicians described the application to be useful and understandable. Conclusion: A high percentage of physicians and health providers are aware of the problems when it comes to hospitalized patients with diabetes and our application was designed to resolve the associated difficulties.


Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association. Diabetes Care 1998;21:296-309.  Back to cited text no. 1
Narayan KM, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F. Diabetes - A common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract 2000;50 Suppl 2:S77-84.  Back to cited text no. 2
World Health Organization. Global Report on Diabetes. Geneva: World Health Organization; 2016.  Back to cited text no. 3
Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000;355:773-8.  Back to cited text no. 4
Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke 2001;32:2426-32.  Back to cited text no. 5
Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE, et al. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978-82.  Back to cited text no. 6
Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL, et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002;40:1748-54.  Back to cited text no. 7
Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 2003;55:33-8.  Back to cited text no. 8
McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ, et al. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 2005;28:810-5.  Back to cited text no. 9
Duggan EW, Carlson K, Umpierrez GE. Perioperative hyperglycemia management: An update. Anesthesiology 2017;126:547-60.  Back to cited text no. 10
Kalladka M, Greenberg BL, Padmashree SM, Venkateshaiah NT, Yalsangi S, Raghunandan BN, et al. Screening for coronary heart disease and diabetes risk in a dental setting. Int J Public Health 2014;59:485-92.  Back to cited text no. 11
Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999;353:89-92.  Back to cited text no. 12
Onat A, Dönmez I, Karadeniz Y, Cakır H, Kaya A. Type-2 diabetes and coronary heart disease: Common physiopathology, viewed from autoimmunity. Expert Rev Cardiovasc Ther 2014;12:667-79.  Back to cited text no. 13
Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011;364:829-41.  Back to cited text no. 14
Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002;287:1003-10.  Back to cited text no. 15
Wong ND, Patao C, Malik S, Iloeje U. Preventable coronary heart disease events from control of cardiovascular risk factors in US adults with diabetes (projections from utilizing the UKPDS risk engine). Am J Cardiol 2014;113:1356-61.  Back to cited text no. 16
Young Adults and Teens Lead Growth Among Smartphone Owners Nielsen: newswire; 2012. Available from: [Last accessed on 2018 Feb 15].  Back to cited text no. 17
Agency Tn. Over 20 Million Iranians use Smart Phones; 10 June, 2015. Available from: [Last accessed on 2018 Mar 17].  Back to cited text no. 18
Teens LA. Smartphones and Texting. Pew Internet and American Life Project; January, 2013. Available from: [Last accessed on 2018 May 21].  Back to cited text no. 19
Carroll JK, Moorhead A, Bond R, LeBlanc WG, Petrella RJ, Fiscella K, et al. Who uses mobile phone health apps and does use matter? A secondary data analytics approach. J Med Internet Res 2017;19:e125.  Back to cited text no. 20
Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-9.  Back to cited text no. 21
Arnhold M, Quade M, Kirch W. Mobile applications for diabetics: A systematic review and expert-based usability evaluation considering the special requirements of diabetes patients age 50 years or older. J Med Internet Res 2014;16:e104.  Back to cited text no. 22